Genetic studies have demonstrated the involvement of the complement regulator factor H in nondiarrheal, nonverocytotoxin (i.e., atypical) cases of hemolytic uremic syndrome. Different factor H mutations have been identified in 10%-30% of patients with atypical hemolytic uremic syndrome (aHUS), and most of these mutations alter single amino acids in the C-terminal region of factor H. Although these mutations are considered to be responsible for the disease, the precise role that factor H plays in the pathogenesis of aHUS is unknown. We report here the structural and functional characterization of three different factor H proteins purified from the plasma of patients with aHUS who carry the factor H mutations W1183L, V1197A, or R1210C. Struct...
Atypical hemolytic uremic syndrome (aHUS) is associated with complement alternative pathway defects ...
Atypical hemolytic uremic syndrome (aHUS) is associated with mutations in the gene CFH encoding the ...
Atypical hemolytic uremic syndrome (aHUS) is associated with complement alternative pathway defects ...
Genetic studies have demonstrated the involvement of the complement regulator factor H in nondiarrhe...
Genetic studies have demonstrated the involvement of the complement regulator factor H in nondiarrhe...
Atypical hemolytic uremic syndrome (aHUS) may be associated with mutations at the C-terminal of fact...
We investigated the phenotypic expression of factor H mutations in two patients with atypical hemoly...
Hemolytic-uremic syndrome (HUS) is a microvasculature disorder leading to microangiopathic hemolytic...
Abstract Atypical hemolytic uremic syndrome (aHUS) is a rare disorder caused by dysregulation of the...
Atypical hemolytic uremic syndrome (aHUS) is associated with mutations in the gene CFH encoding the ...
Atypical hemolytic uremic syndrome (aHUS) is associated with mutations in the gene CFH encoding the ...
Abstract Atypical hemolytic uremic syndrome (aHUS) is a rare disorder caused by dysregulation of the...
The complement system plays an important role in our innate immune system. Complement activation res...
Atypical hemolytic uremic syndrome (aHUS) is associated with complement alternative pathway defects ...
Atypical hemolytic uremic syndrome (aHUS) is associated with complement alternative pathway defects ...
Atypical hemolytic uremic syndrome (aHUS) is associated with complement alternative pathway defects ...
Atypical hemolytic uremic syndrome (aHUS) is associated with mutations in the gene CFH encoding the ...
Atypical hemolytic uremic syndrome (aHUS) is associated with complement alternative pathway defects ...
Genetic studies have demonstrated the involvement of the complement regulator factor H in nondiarrhe...
Genetic studies have demonstrated the involvement of the complement regulator factor H in nondiarrhe...
Atypical hemolytic uremic syndrome (aHUS) may be associated with mutations at the C-terminal of fact...
We investigated the phenotypic expression of factor H mutations in two patients with atypical hemoly...
Hemolytic-uremic syndrome (HUS) is a microvasculature disorder leading to microangiopathic hemolytic...
Abstract Atypical hemolytic uremic syndrome (aHUS) is a rare disorder caused by dysregulation of the...
Atypical hemolytic uremic syndrome (aHUS) is associated with mutations in the gene CFH encoding the ...
Atypical hemolytic uremic syndrome (aHUS) is associated with mutations in the gene CFH encoding the ...
Abstract Atypical hemolytic uremic syndrome (aHUS) is a rare disorder caused by dysregulation of the...
The complement system plays an important role in our innate immune system. Complement activation res...
Atypical hemolytic uremic syndrome (aHUS) is associated with complement alternative pathway defects ...
Atypical hemolytic uremic syndrome (aHUS) is associated with complement alternative pathway defects ...
Atypical hemolytic uremic syndrome (aHUS) is associated with complement alternative pathway defects ...
Atypical hemolytic uremic syndrome (aHUS) is associated with mutations in the gene CFH encoding the ...
Atypical hemolytic uremic syndrome (aHUS) is associated with complement alternative pathway defects ...